
Results 1 - 20 of 82 in Effexor, Venlafaxine (generic)
PATIENTS could pay more for the most common medicines after the Rudd Government moved to stop drug companies cashing-in on taxpayer subsidies. Comment?
New antidepressant funded by PHARMAC
New Zealand's drug-buying agency is hoping to save a few dollars with the introduction of a new antidepressant. Comment?
Newly-funded antidepressant to meet unmet need
Sunday, 1 November 2009, 5:56 pm Press Release: PHARMAC 1 November, 2009 Media release Newly-funded antidepressant to meet unmet need – PHARMAC An antidepressant that will be funded from 1 November will help meet an unmet need for people with severe depression, says PHARMAC's medical director Dr Peter Moodie. Comment?
Treatment with SSRIs or venlaxafine associated with increased risk of GI bleeding
In a nested, case-control study published in the Archives of General Psychiatry, investigators observed that the use of selective serotonin-reuptake inhibitors increased the risk of upper gastrointestinal tract bleeding; this increased risk was also observed with the serotonin and norepinephrine reuptake inhibitor venlafaxine. Comment?
Research and Markets: Commercial Insight: Antidepressants - Novel...
Research and Markets: Commercial Insight: Antidepressants - Novel Mechanism Offers Hope In Depressed Market - Market to Decline at a Rate of -2.0% Between 2008 and 2018 With current blockbuster brands facing generic competition, Datamonitor forecasts the antidepressant market to decline at a compound annual growth rate of -2.0% between 2008 and ... Comment?
Are Antidepressant Drugs Actually Worth Taking?
THE QUESTION Irving Kirsch no longer sends patients to seek out antidepressants. Comment?
Slight OD of popular antidepressant could cause death
B.C. doctors are being put on alert that the most commonly prescribed antidepressant in B.C. is increasingly being observed to have toxic overdose consequences such as seizures and even deaths. Comment?
Hope may be new `pill' for depression
Irving Kirsch shook up the mental health field this week when he and his team reported ``happy pills'' swallowed by millions of Canadians every day are virtually no better than dummy drugs at treating depression. Comment?
Here's one problem with health care...
The country is Australia, but the problem is universal. In March, during a single weekend meeting down under, Wyeth spent more than $1 million on a "meeting" for doctors to promote its drug Pristiq . Comment?
BBC news said today that "children born to women taking anti-depressants in early pregnancy have a small but important increased risk of heart defects". It reported on a Danish study that looked at over 400,000 children born between 1996 and 2003. Comment?
Aspect Medical Systems , maker of the bispectral index monitor thought to be useful for monitoring anesthesia awareness, has been dealt a devastating blow last year by a study published in NEJM under the title Anesthesia Awareness and the Bispectral Index . Comment?
Hot flashes in men just as annoying
You're sitting in a meeting and suddenly a participant leans back, exhales and starts doing the fanning thing. Comment?
Breakthrough new drug for depression sufferers
w/Photo
DEPRESSION sufferers may have a more effective drug open to them than Prozac, according to new research. Comment?
New Depression Drug Is 'Better Than Prozac'
w/Photo
A new drug is more effective than Prozac in treating depression, research released today indicates. Comment?
New Depression Drug Is 'Better Than Prozac'
w/Photo
A new drug is more effective than Prozac in treating depression, research released today indicates. Comment?
A new drug is more effective than Prozac in treating depression, research out today suggests.
The 30-a-month drug agomelatine was found to help 77.7% of people with severe depression compared with 68.8% on Prozac, a study comparing the drugs found. Comment?
Most men won't want to shave armpits
Q : I enjoyed reading your article about using old-fashioned Listerine for smelly armpits. 2 comments
Aspect Medical Systems Announces Publication of BRITE-MD Trial Results in Psychiatry Research
Aspect Medical Systems, Inc . today announced that two companion articles highlighting results from the BRITE-MD were published in the September issue of the journal Psychiatry Research . Comment?
Controlled-release formulations targeted by generic companies
Generic-drug companies are increasingly viewing the development of controlled-release formulations as a way of obtaining a competitive edge, according to a report published by Espicom Business Intelligence in August 2009. Comment?
DRUG CLASS AND MECHANISM: Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor used for treating pain associated with fibromyalgia . Comment?